Please login to the form below

COUCH Health recruits Rosemary Lakeru as Director of Patient Recruitment, Feasibility and Diversity

With the appointment of Rosemary Lakeru as Director of Patient Recruitment, Feasibility and Diversity, COUCH Health becomes one of the first patient engagement companies to create a senior role with a specific focus on improving diversity in clinical trials.

PRESS RELEASE

Date: Tuesday 3 November 2020

For immediate release

COUCH Health recruits Rosemary Lakeru as Director of Patient Recruitment, Feasibility and Diversity

Better patient diversity is critical for clinical trials, in order to develop the right drugs for the right patients, and to support successful drug approvals and effective marketing and communication campaigns. With the appointment of Rosemary Lakeru as Director of Patient Recruitment, Feasibility and Diversity, COUCH Health becomes one of the first patient engagement companies to create a senior role with a specific focus on improving diversity in clinical trials.

An experienced recruitment and retention specialist, Lakeru understands the importance of enrolling patients from a broader pool to better reflect the heterogeneity of the general population. "We can only create treatments that meet the needs of ordinary patients if we test them on a representative cohort of people in the first place," said Lakeru.

Lakeru brings a patient-centred approach with strategic solutions that support the vital goals of better patient support and greater diversity.

"I believe that connecting and communicating with patients, and empowering them before, during, and after their participation in a trial, can improve retention and help companies to reach their enrolment goals. I also want to improve the clinical trial process and experience for patients by making it simple, transparent, and accessible," said Lakeru.

Despite increasing pressure from regulators, clinical trials are often carried out on a largely white and male population. As an example, of 46,391 study volunteers who contributed to clinical studies of new drugs in 2019, only 9% of people involved were black/African American, 9% were Asian, and 18% were Hispanic. Women, particularly older women, are under-represented in cancer clinical trials. This results in drugs that are not fully tested in the people who will take them.

Ash Rishi, CEO of COUCH Health said: "We are excited to welcome Rosemary Lakeru. Clinical trials must become more inclusive – it’s the only way to develop effective treatments. Drug licensing and regulatory bodies are increasingly asking for evidence of drug safety and efficacy in diverse populations; the industry can no longer avoid the issue. It’s important that everyone involved with clinical research takes responsibility for tackling this issue and that we do so decisively and that is why we have taken this important step and ensuring that whenever we do any patient recruitment we ensure diversity is at the heart of what we do."

-Ends-

For more information, please contact Ash Rishi at COUCH Health on + 44 (0) 330 995 0656 or hello@couchhealth.co.

Notes to editors

About COUCH Health

COUCH Health is a patient engagement agency dedicated to improving clinical trial experiences for patients. It works with pharmaceutical, biotech and life science companies to improve patient insights, recruitment and retention for clinical trials. In May 2020, COUCH Health launched its Demand Diversity campaign for clinical trials to become more diverse and inclusive.

For more information, visit www.couchhealth.co.

3rd November 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions.
COUCH Health
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?
COUCH Health
Clinical trial design and how it can be used to improve the patient experience
For this article, we want to go back to basics and describe the main features of the most commonly used designs for clinical trials, why they are set-up in this way, and how they can be used to benefit the patient experience.
COUCH Health
What to do and what to avoid when writing about ethnicity
It’s always important to talk about ethnicity, especially when it comes to talking about diversity in clinical trials. It’s also important to know how to talk about ethnicity too. So, we’ve made you a step-by-step guide on what you should and shouldn’t do when talking and writing about ethnicity. Let’s get stuck in.
COUCH Health
Is your clinical trial method tried and tested with patients in mind?
As you may know, we talk about putting patients first, a lot. This means thinking about patients when discussing, writing and designing recruitment materials, whilst also using a multi-method approach. For example, there are huge benefits in using direct patient insights from advocacy groups, as well as conducting social listening exercises. If you utilise these approaches, you’re more likely to engage with the patient population as effectively as possible. This is what creates successful patient recruitment strategies. Makes sense, right?
COUCH Health
Clinical trial branding: 5 reasons it’s important to your clinical trials
Your clinical trial is one of hundreds of thousands enrolling patients at any given time. You’ve got to ask yourself, what makes my study different? Why enrol in my study?
COUCH Health